Royal Marsden NHS Foundation Trust: Melanoma trials

The registry lists 10 Melanoma studies with Royal Marsden NHS Foundation Trust as lead sponsor. 4 are open to participants now and 2 have results posted.

Phase 1 2Phase 2 4No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Power of Liquid Biopsy Tracking in Immunotherapy Treated Stage IV MelanomaNot yet recruitingNCT06710093
• CARDiac Toxicity Following ImmunOtherapy Treatment for MelanomaEnrolling by invitationNCT06605833
• Preoperative Planning With PSMA-PET in Melanoma Surgery TrialRecruitingNCT06560905Phase 2
• LATe TreatmENT Related Toxicity in Melanoma (LATENT)Not yet recruitingNCT06414343
• Trial of Pembrolizumab and Radiotherapy in MelanomaTerminatedNCT02562625Phase 2Results posted
• Dose Escalation Study With Expansion to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of CCT3833CompletedNCT02437227Phase 1Results posted
• TITAN (Tumoural Injection of T-VEC and Isolated Limb Perfusion)CompletedNCT03555032Phase 1/2
• A Study of Anti-PD-1 (Pembrolizumab) Therapy in Metastatic Melanoma (ADAPTeM)WithdrawnNCT02663258Phase 2
• Pain Prevalence and Risk Factors Among Sarcoma/Melanoma Oncology Patients in an Outpatients SettingCompletedNCT01034696
• The Identification of Novel Prognostic Markers in MelanomaStatus unknownNCT01002560